ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.098,09
-0,50%
S&P 500
5.277,51
0,80%
US Dollar vs BRL
5,2459
0,00%
Bitcoin
67.587,25
0,16%
Brent Oil
81,295
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Renalytix PLC (RNLX)

  7. Renalytix PLC (RNLX) Notícias

RNLX

Renalytix (RNLX)

Renalytix PLC
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:RNLX
DataHoraFonteTítuloCódigoCompanhia
28/05/202408:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RNLXRenalytix PLC
15/05/202411:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RNLXRenalytix PLC
15/05/202408:20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RNLXRenalytix PLC
15/05/202408:00GlobeNewswire Inc.Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
09/05/202408:00GlobeNewswire Inc.Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15NASDAQ:RNLXRenalytix PLC
08/04/202408:00GlobeNewswire Inc.Renalytix Announces Financing with Expected Size of up to $4 MillionNASDAQ:RNLXRenalytix PLC
14/03/202408:00GlobeNewswire Inc.KidneyIntelX™ included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)NASDAQ:RNLXRenalytix PLC
15/02/202409:00GlobeNewswire Inc.Renalytix Reports Financial Results for Second Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
09/02/202411:00GlobeNewswire Inc.Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceNASDAQ:RNLXRenalytix PLC
10/01/202409:00GlobeNewswire Inc.New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney diseaseNASDAQ:RNLXRenalytix PLC
17/11/202318:01Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:RNLXRenalytix PLC
14/11/202309:00GlobeNewswire Inc.Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024NASDAQ:RNLXRenalytix PLC
07/11/202309:00GlobeNewswire Inc.Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14NASDAQ:RNLXRenalytix PLC
03/11/202317:04Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:RNLXRenalytix PLC
06/10/202308:00GlobeNewswire Inc.US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to RenalytixNASDAQ:RNLXRenalytix PLC
28/09/202308:00GlobeNewswire Inc.Renalytix Reports Full Year Fiscal 2023 ResultsNASDAQ:RNLXRenalytix PLC
25/09/202308:00GlobeNewswire Inc.Renalytix to Report Financial Results for Fourth Quarter and Full Year Fiscal 2023 on September 28NASDAQ:RNLXRenalytix PLC
07/09/202308:00GlobeNewswire Inc.Renalytix Appoints Senior Executive Howard Doran as Chief Business OfficerNASDAQ:RNLXRenalytix PLC
03/08/202308:00GlobeNewswire Inc.Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkdNASDAQ:RNLXRenalytix PLC
21/07/202308:00GlobeNewswire Inc.Renalytix Announces Middle East Distribution Agreement with Vector PharmaNASDAQ:RNLXRenalytix PLC
07/07/202308:00GlobeNewswire Inc.Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific SessionsNASDAQ:RNLXRenalytix PLC
03/07/202308:00GlobeNewswire Inc.Renalytix Appoints Financial Executive Catherine Coste to its Board of DirectorsNASDAQ:RNLXRenalytix PLC
30/06/202308:01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:RNLXRenalytix PLC
29/06/202319:58Dow Jones NewsRenalytix Gets FDA De Novo Marketing Authorization for KidneyIntelX.dkdNASDAQ:RNLXRenalytix PLC
29/06/202319:01GlobeNewswire Inc.FDA Grants De Novo Marketing Authorization for KidneyIntelX.dkd to Assess Risk of Progressive Kidney Function Decline in Adults with Diabetes and Early-Stage Kidney DiseaseNASDAQ:RNLXRenalytix PLC
15/06/202308:00GlobeNewswire Inc.KidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific ConferencesNASDAQ:RNLXRenalytix PLC
09/06/202308:00GlobeNewswire Inc.Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023NASDAQ:RNLXRenalytix PLC
05/06/202308:00GlobeNewswire Inc.Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9NASDAQ:RNLXRenalytix PLC
25/05/202308:00GlobeNewswire Inc.Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 DiabetesNASDAQ:RNLXRenalytix PLC
11/05/202307:07Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RNLXRenalytix PLC
 Apresentando as notícias mais relevantes sobre:NASDAQ:RNLX

Seu Histórico Recente

COIN
NETKOUSD
TSXV
AET
Aethon Minerals
TSXV
GOT
Goliath Resources
BITMOT
2891070
Aiib Fx 45% Oct24 Try
COIN
2GOUSD
COIN
FTRRETH
Future Coin
BOV
CMCS34M
Comcast DRN MB
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados